•Dais and SOEX (
•SOEX, as part of the equity purchase, entered into a voting agreement with Dais which finds SOEX agreeing to vote as recommended by the Dais's board of directors for a one-year period beginning on the date the shares are issued to SOEX.
•Dais plans to use the proceeds from the sale of the Common Stock for working capital, business development in other targeted areas, general business purposes, and to pay its portion of the
•Dais-SOEX is being incorporated in
•Dais and SOEX shall complete the negotiations of a master distributor agreement with a SOEX-designated entity, and a license and supply agreement for Dais-SOEX inside the next two months for the purchase and sale of ConsERV and Aqualyte materials for ventilation air, and clean water applications. The Parties have agreed these documents will contain normal commercial terms and conditions (including sales minimums and uses of intellectual property). The SOEX designated entity will built ConsERV cores and systems in
"Our team has been seeking a disruptive technology able to move sustainability products to new levels which can use SOEX's manufacturing and distribution channels. Combining the demonstrated strengths of Dais's nanomaterial and its strong team with the in-place quality manufacturing, distribution assets and team at SOEX, and of SOEX's
SOEX-Beijing's earliest incorporation was in 1996 with its first company. Its Panelwell construction materials business is now an industry leader in hollow profile 'Penelwell' line of materials built around a variety of high quality plastics notably polycarbonates. Its distribution access is strong within
•ConsERV™, a commercial engineered energy recovery ventilator (an HVAC product) useful for efficient management of ventilation air's temperature and moisture content using the energy found in the outgoing 'stale' air stream to pre-condition the incoming fresh air saving energy, lessening CO2 emissions, and allowing for HVAC equipment downsizing;
•NanoClear™, a beta-stage method for treating contaminated water (sea, waste, industrial) to provide 1,000 times cleaner potable water; and;
•NanoAir™, an early beta-stage water-based cooling cycle using no fluorocarbon refrigerants that replaces the existing vapor compression cooling cycle in most forms of air-conditioning and refrigeration, saving a projected 50% in energy and CO2, and;
•NanoCap™, a prototype stage energy storage device which holds promise to use the Aqualyte™ family to form a disruptive non-chemical energy-storage device (an ultra capacitor) for use in transportation, renewable energy, and 'smart grid' configurations.
Each use demonstrates the diversity of Dais' core product -- Aqualyte™ -- a family of nano-structured polymers and engineered processes having a focus on minimizing consumption of irreplaceable natural resources, and ending the degradation of our environment. To find out more about Dais please visit www.daisanalytic.com, and to learn more about ConsERV please visit www.conserv.com.
Safe Harbor Statement
This press release includes statements that may constitute forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Statements that are not historical facts, including statements about the Company's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. For example, statements about the future sales volume are forward looking and subject to risks. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. Potential risks and uncertainties include, but are not limited to, risks outlined in the Company's filings with the
Dais Analytic CorporationPamela.email@example.com